Invasive Fungal Infections in Patients with Chronic Granulomatous Disease

  • Stefanie Henriet
  • Paul E. Verweij
  • Steven M. Holland
  • Adilia Warris
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB)

Abstract

Invasive fungal infections are a major threat for chronic granulomatous disease (CGD) patients. The present study provides a comprehensive overview of published invasive fungal infections in the CGD host through an extensive review of epidemiological, clinical, diagnostic and therapeutic data. In addition to the often mild clinical presentation, the currently used diagnostics for invasive aspergillosis have low sensitivity in CGD patients and cannot be easily translated to this non-neutropenic host. Aspergillus fumigatus and A. nidulans are the most commonly isolated species. A. nidulans infections are seldom reported in other immunocompromised patients, indicating a unique interaction between this fungus and the CGD host. The occurrence of mucormycosis is mainly noted in the setting of treatment of inflammatory complications with immunosuppressive drugs. Candida infections are infrequently seen and do not cause mucocutaneous disease but do show an age-dependent clinical presentation. The CGD patient is susceptible to a wide range of fungal pathogens, indicating the need to determine the causative fungus, often by invasive diagnostics, to guide optimal and rational treatment. This review summarizes current understanding of invasive fungal infections in patients with CGD and will serve as a starting point to guide optimal treatment strategies and to direct further research aimed at improving outcomes.

Keywords

Fungal Infection Antifungal Therapy Invasive Aspergillosis Chronic Granulomatous Disease Invasive Fungal Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Jones LB, McGrogan P, Flood TJ, Gennery AR, Morton L, Thrasher A et al (2008) Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol 152(2):211–218PubMedCrossRefGoogle Scholar
  2. 2.
    Hasui M (1999) Chronic granulomatous disease in Japan: incidence and natural history. The Study Group of Phagocyte Disorders of Japan. Pediatr Int 41(5):589–593PubMedCrossRefGoogle Scholar
  3. 3.
    Ahlin A, De Boer M, Roos D, Leusen J, Smith CI, Sundin U et al (1995) Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 84(12):1386–1394PubMedCrossRefGoogle Scholar
  4. 4.
    Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI et al (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 79(3):155–169PubMedCrossRefGoogle Scholar
  5. 5.
    Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C (1989) Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 114(4 Pt 1):555–560PubMedGoogle Scholar
  6. 6.
    Kosut JS, Kamani NR, Jantausch BA (2006) One-month-old infant with multilobar round pneumonias. Pediatr Infect Dis J 25(1):95–97PubMedCrossRefGoogle Scholar
  7. 7.
    Alsultan A, Williams MS, Lubner S, Goldman FD (2006) Chronic granulomatous disease presenting with disseminated intracranial aspergillosis. Pediatr Blood Cancer 47(1):107–110PubMedCrossRefGoogle Scholar
  8. 8.
    Wang SM, Shieh CC, Liu CC (2005) Successful treatment of Paecilomyces variotii splenic abscesses: a rare complication in a previously unrecognized chronic granulomatous disease child. Diagn Microbiol Infect Dis 53(2):149–152PubMedCrossRefGoogle Scholar
  9. 9.
    Mansoory D, Roozbahany NA, Mazinany H, Samimagam A (2003) Chronic Fusarium infection in an adult patient with undiagnosed chronic granulomatous disease. Clin Infect Dis 37(7):e107–e108PubMedCrossRefGoogle Scholar
  10. 10.
    Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert CM, Gutman L et al (1981) Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med 71(1):59–66PubMedCrossRefGoogle Scholar
  11. 11.
    Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM (2000) Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine 79(3):170–200PubMedCrossRefGoogle Scholar
  12. 12.
    Denning DW (1998) Invasive aspergillosis. Clin Infect Dis 26(4):781–803PubMedCrossRefGoogle Scholar
  13. 13.
    Zaoutis TE, Heydon K, Chu JH, Walsh TJ, Steinbach WJ (2006) Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 117(4):e711–e716PubMedCrossRefGoogle Scholar
  14. 14.
    Steinbach WJ (2010) Epidemiology of Invasive Fungal Infections in Neonates and Children. Clin Microbiol Infect 16(9):1321–1327PubMedCrossRefGoogle Scholar
  15. 15.
    Groll AH, Kurz M, Schneider W, Witt V, Schmidt H, Schneider M et al (1999) Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival. Mycoses 42(7–8):431–442PubMedCrossRefGoogle Scholar
  16. 16.
    Crassard N, Hadden H, Piens MA, Pondarre C, Hadden R, Galambrun C et al (2008) Invasive aspergillosis in a paediatric haematology department: a 15-year review. Mycoses 51(2):109–116PubMedCrossRefGoogle Scholar
  17. 17.
    Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H (2000) Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 26(9):999–1004PubMedCrossRefGoogle Scholar
  18. 18.
    van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L et al (2009) Chronic granulomatous disease: the European experience. PLoS ONE 4(4):e5234PubMedCrossRefGoogle Scholar
  19. 19.
    Kobayashi S, Murayama S, Takanashi S, Takahashi K, Miyatsuka S, Fujita T et al (2008) Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan. Eur J Pediatr 167(12):1389–1394PubMedCrossRefGoogle Scholar
  20. 20.
    Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A et al (2008) Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol 126(2):155–164PubMedCrossRefGoogle Scholar
  21. 21.
    Almyroudis NG, Holland SM, Segal BH (2005) Invasive aspergillosis in primary immunodeficiencies. Med Mycol 43(Suppl 1):S247–S259PubMedCrossRefGoogle Scholar
  22. 22.
    Mamishi S, Parvaneh N, Salavati A, Abdollahzadeh S, Yeganeh M (2007) Invasive aspergillosis in chronic granulomatous disease: report of 7 cases. Eur J Pediatr 166(1):83–84PubMedCrossRefGoogle Scholar
  23. 23.
    Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM (1998) Aspergillus nidulans infection in chronic granulomatous disease. Medicine 77(5):345–354PubMedCrossRefGoogle Scholar
  24. 24.
    White CJ, Kwon-Chung KJ, Gallin JI (1988) Chronic granulomatous disease of childhood. An unusual case of infection with Aspergillus nidulans var. echinulatus. Am J Clin Pathol 90(3):312–316PubMedGoogle Scholar
  25. 25.
    Dotis J, Roilides E (2004) Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Int J Infect Dis 8(2):103–110PubMedCrossRefGoogle Scholar
  26. 26.
    Antachopoulos C, Walsh TJ, Roilides E (2007) Fungal infections in primary immunodeficiencies. Eur J Pediatr 166(11):1099–1117PubMedCrossRefGoogle Scholar
  27. 27.
    Roilides E, Zaoutis TE, Walsh TJ (2009) Invasive zygomycosis in neonates and children. Clin Microbiol Infect 15(Suppl 5):50–54PubMedCrossRefGoogle Scholar
  28. 28.
    Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL et al (2005) Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41(5):634–653PubMedCrossRefGoogle Scholar
  29. 29.
    Zaoutis TE, Roilides E, Chiou CC, Buchanan WL, Knudsen TA, Sarkisova TA et al (2007) Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis J 26(8):723–727PubMedCrossRefGoogle Scholar
  30. 30.
    Vinh DC, Freeman AF, Shea YR, Malech HL, Abinun M, Weinberg GA et al (2009) Mucormycosis in chronic granulomatous disease: association with iatrogenic immunosuppression. J Allergy Clin Immunol 123(6):1411–1413PubMedCrossRefGoogle Scholar
  31. 31.
    Baehner RL, Nathan DG (1967) Leukocyte oxidase: defective activity in chronic granulomatous disease. Science 155(764):835–836PubMedCrossRefGoogle Scholar
  32. 32.
    Vowells SJ, Fleisher TA, Sekhsaria S, Alling DW, Maguire TE, Malech HL (1996) Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr 128(1):104–107PubMedCrossRefGoogle Scholar
  33. 33.
    Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA (1995) Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 178(1):89–97PubMedCrossRefGoogle Scholar
  34. 34.
    Berendes H, Bridges RA, Good RA (1957) A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med 40(5):309–312PubMedGoogle Scholar
  35. 35.
    de Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46(12):1813–1821PubMedCrossRefGoogle Scholar
  36. 36.
    Kelly JK, Pinto AR, Whitelaw WA, Rorstad OP, Bowen TJ, Matheson DS (1986) Fatal Aspergillus pneumonia in chronic granulomatous disease. Am J Clin Pathol 86(2):235–240PubMedGoogle Scholar
  37. 37.
    Siddiqui S, Anderson VL, Hilligoss DM, Abinun M, Kuijpers TW, Masur H et al (2007) Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clin Infect Dis 45(6):673–681PubMedCrossRefGoogle Scholar
  38. 38.
    Gupta A, McKean M, Haynes S, Wright C, Barge D, Flood TJ et al (2009) Chronic granulomatous disease presenting as fulminant Aspergillus pneumonitis: a lethal combination? Pediatr Crit Care Med 10(4):e43–e45PubMedCrossRefGoogle Scholar
  39. 39.
    Conrad DJ, Warnock M, Blanc P, Cowan M, Golden JA (1992) Microgranulomatous aspergillosis after shoveling wood chips: report of a fatal outcome in a patient with chronic granulomatous disease. Am J Ind Med 22(3):411–418PubMedCrossRefGoogle Scholar
  40. 40.
    Abinun M, Wright C, Gould K, Flood TJ, Cassidy J (2007) Absidia corymbifera in a patient with chronic granulomatous disease. Pediatr Infect Dis J 26(12):1167–1168PubMedGoogle Scholar
  41. 41.
    Eppinger TM, Greenberger PA, White DA, Brown AE, Cunningham-Rundles C (1999) Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J Allergy Clin Immunol 104(6):1265–1272PubMedCrossRefGoogle Scholar
  42. 42.
    Vinh DC, Shea YR, Jones PA, Freeman AF, Zelazny A, Holland SM (2009) Chronic invasive aspergillosis caused by Aspergillus viridinutans. Emerg Infect Dis 15(8):1292–1294PubMedCrossRefGoogle Scholar
  43. 43.
    Sponseller PD, Malech HL, McCarthy EF Jr, Horowitz SF, Jaffe G, Gallin JI (1991) Skeletal involvement in children who have chronic granulomatous disease. J Bone Joint Surg Am 73(1):37–51PubMedGoogle Scholar
  44. 44.
    Hodiamont CJ, Dolman KM, Ten Berge IJ, Melchers WJ, Verweij PE, Pajkrt D (2009) Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery. Med Mycol 47(2):217–220PubMedCrossRefGoogle Scholar
  45. 45.
    Bodur H, Ozoran K, Colpan A, Balaban N, Tabak Y, Kulacoglu S (2003) Arthritis and osteomyelitis due to Aspergillus fumigatus: a 17 years old boy with chronic granulomatous disease. Ann Clin Microbiol Antimicrob 2:2PubMedCrossRefGoogle Scholar
  46. 46.
    Dotis J, Panagopoulou P, Filioti J, Winn R, Toptsis C, Panteliadis C et al (2003) Femoral osteomyelitis due to Aspergillus nidulans in a patient with chronic granulomatous disease. Infection 31(2):121–124PubMedCrossRefGoogle Scholar
  47. 47.
    Davis CM, Noroski LM, Dishop MK, Sutton DA, Braverman RM, Paul ME et al (2007) Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease. Pediatr Infect Dis J 26(7):655–656PubMedCrossRefGoogle Scholar
  48. 48.
    Galluzzo ML, Hernandez C, Davila MT, Perez L, Oleastro M, Zelazko M et al (2008) Clinical and histopathological features and a unique spectrum of organisms significantly associated with chronic granulomatous disease osteomyelitis during childhood. Clin Infect Dis 46(5):745–749PubMedCrossRefGoogle Scholar
  49. 49.
    Wolfson JJ, Kane WJ, Laxdal SD, Good RA, Quie PG (1969) Bone findings in chronic granulomatous disease of childhood. A genetic abnormality of leukocyte function. J Bone Joint Surg Am 51(8):1573–1583PubMedGoogle Scholar
  50. 50.
    Sillevis Smitt JH, Leusen JH, Stas HG, Teeuw AH, Weening RS (1997) Chronic bullous disease of childhood and a paecilomyces lung infection in chronic granulomatous disease. Arch Dis Child 77(2):150–152PubMedCrossRefGoogle Scholar
  51. 51.
    Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE et al (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363(27):2600–2610PubMedCrossRefGoogle Scholar
  52. 52.
    Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, naya-O’Brien S et al (2004) Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 114(2):462–468PubMedCrossRefGoogle Scholar
  53. 53.
    Dekkers R, Verweij PE, Weemaes CM, Severijnen RS, Van Krieken JH, Warris A (2008) Gastrointestinal zygomycosis due to Rhizopus microsporus var. rhizopodiformis as a manifestation of chronic granulomatous disease. Med Mycol 46(5):491–494PubMedCrossRefGoogle Scholar
  54. 54.
    Levy O, Bourquin JP, McQueen A, Cantor AB, Lachenauer C, Malley R (2002) Fatal disseminated Candida lusitaniae infection in an infant with chronic granulomatous disease. Pediatr Infect Dis J 21(3):262–264PubMedCrossRefGoogle Scholar
  55. 55.
    Estrada B, Mancao MY, Polski JM, Figarola MS (2006) Candida lusitaniae and chronic granulomatous disease. Pediatr Infect Dis J 25(8):758–759PubMedCrossRefGoogle Scholar
  56. 56.
    Khoo BH, Cho CT, Smith SD, Dudding BA (1975) Letter: cervical lymphadenitis due to Candida albicans infection.920c. J Pediatr 86(5):812–813PubMedCrossRefGoogle Scholar
  57. 57.
    Saulsbury FT (2001) Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease. Clin Infect Dis 32(10):E137–E139PubMedCrossRefGoogle Scholar
  58. 58.
    Patiroglu T, Unal E, Yikilmaz A, Koker MY, Ozturk MK (2010) Atypical presentation of chronic granulomatous disease in an adolescent boy with frontal lobe located Aspergillus abscess mimicking intracranial tumor. Childs Nerv Syst 26(2):149–154PubMedCrossRefGoogle Scholar
  59. 59.
    Hipolito E, Faria E, Alves AF, De Hoog GS, Anjos J, Goncalves T et al (2009) Alternaria infectoria brain abscess in a child with chronic granulomatous disease. Eur J Clin Microbiol Infect Dis 28(4):377–380PubMedCrossRefGoogle Scholar
  60. 60.
    Agus S, Spektor S, Israel Z (2000) CNS granulomatosis in a child with chronic granulomatous disease. Br J Neurosurg 14(1):59–61PubMedCrossRefGoogle Scholar
  61. 61.
    Fleischmann J, Church JA, Lehrer RI (1986) Primary Candida meningitis and chronic granulomatous disease. Am J Med Sci 291(5):334–341PubMedCrossRefGoogle Scholar
  62. 62.
    Ferris B, Jones C (1985) Paraplegia due to aspergillosis. Successful conservative treatment of two cases. J Bone Joint Surg Br 67(5):800–803PubMedGoogle Scholar
  63. 63.
    Miron D, Horowitz Y, Lumelsky D, Hanania S, Colodner R (2005) Dual pulmonary infection with Candida dubliniensis and Aspergillus fumigatus in a child with chronic granulomatous disease. J Infect 50(1):72–75PubMedCrossRefGoogle Scholar
  64. 64.
    de Sevaux RG, Kullberg BJ, Verweij PE, van de Nes JA, Meis JF, van der Meer JW (1998) Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole. Clin Infect Dis 26(4):996–997PubMedCrossRefGoogle Scholar
  65. 65.
    Mouy R, Ropert JC, Donadieu J, Hubert P, de Blic J, Revillon Y et al (1995) Chronic septic granulomatosis revealed by neonatal pulmonary aspergillosis. Arch Pediatr 2(9):861–864PubMedCrossRefGoogle Scholar
  66. 66.
    Chusid MJ, Sty JR, Wells RG (1988) Pulmonary aspergillosis appearing as chronic nodular disease in chronic granulomatous disease. Pediatr Radiol 18(3):232–234PubMedCrossRefGoogle Scholar
  67. 67.
    Pasic S, Abinun M, Pistignjat B, Vlajic B, Rakic J, Sarjanovic L et al (1996) Aspergillus osteomyelitis in chronic granulomatous disease: treatment with recombinant gamma-interferon and itraconazole. Pediatr Infect Dis J 15(9):833–834PubMedCrossRefGoogle Scholar
  68. 68.
    Kloss S, Schuster A, Schroten H, Lamprecht J, Wahn V (1991) Control of proven pulmonary and suspected CNS aspergillus infection with itraconazole in a patient with chronic granulomatous disease. Eur J Pediatr 150(7):483–485PubMedCrossRefGoogle Scholar
  69. 69.
    Elgefors B, Haugstvedt S, Brorsson JE, Esbjorner E (1980) Disseminated aspergillosis treated with amphotericin B and surgery in a boy with chronic granulomatous disease. Infection 8(4):174–176PubMedCrossRefGoogle Scholar
  70. 70.
    van ’t Wout JW, Raven EJ, van der Meer JW (1990) Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease. J Infect 20(2):147–150PubMedCrossRefGoogle Scholar
  71. 71.
    Heinrich SD, Finney T, Craver R, Yin L, Zembo MM (1991) Aspergillus osteomyelitis in patients who have chronic granulomatous disease. Case report. J Bone Joint Surg Am 73(3):456–460PubMedGoogle Scholar
  72. 72.
    Galimberti R, Kowalczuk A, Hidalgo P I, Gonzalez RM, Flores V (1998) Cutaneous aspergillosis: a report of six cases. Br J Dermatol 139(3):522–526PubMedCrossRefGoogle Scholar
  73. 73.
    Watanabe C, Yajima S, Taguchi T, Toya K, Fujii Y, Hongo T et al (2001) Successful unrelated bone marrow transplantation for a patient with chronic granulomatous disease and associated resistant pneumonitis and Aspergillus osteomyelitis. Bone Marrow Transplant 28(1):83–87PubMedCrossRefGoogle Scholar
  74. 74.
    Pollack IF, Pang D, Schuit KE (1987) Chronic granulomatous disease with cranial fungal osteomyelitis and epidural abscess. Case report. J Neurosurg 67(1):132–136PubMedCrossRefGoogle Scholar
  75. 75.
    Kline MW, Bocobo FC, Paul ME, Rosenblatt HM, Shearer WT (1994) Successful medical therapy of Aspergillus osteomyelitis of the spine in an 11-year-old boy with chronic granulomatous disease. Pediatrics 93(5):830–835PubMedGoogle Scholar
  76. 76.
    Yeh J, Culbertson C, Petru AM (2009) Purulent pericardial effusion in a 14-year-old girl. Pediatr Infect Dis J 28(12):1140, 1147–1148Google Scholar
  77. 77.
    Verweij PE, Weemaes CM, Curfs JH, Bretagne S, Meis JF (2000) Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 38(10):3900–3901PubMedGoogle Scholar
  78. 78.
    Chatzipanagiotou S, Takou K, Perogamvros A (1998) Cutaneous purulent aspergillosis in a young man with chronic granulomatous disease. Mycoses 41(9–10):379–382PubMedCrossRefGoogle Scholar
  79. 79.
    Dohil M, Prendiville JS, Crawford RI, Speert DP (1997) Cutaneous manifestations of chronic granulomatous disease. A report of four cases and review of the literature. J Am Acad Dermatol 36(6 Pt 1):899–907PubMedCrossRefGoogle Scholar
  80. 80.
    Palmero ML, Pope E, Brophy J (2009) Sporotrichoid aspergillosis in an immunocompromised child: a case report and review of the literature. Pediatr Dermatol 26(5):592–596PubMedCrossRefGoogle Scholar
  81. 81.
    Arendrup MC, Mavridou E, Mortensen KL, Snelders E, Frimodt-Moller N, Khan H et al (2010) Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS ONE 5(4):e10080PubMedCrossRefGoogle Scholar
  82. 82.
    Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA et al (2008) Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5(11):e219PubMedCrossRefGoogle Scholar
  83. 83.
    Verweij PE, Mellado E, Melchers WJ (2007) Multiple-triazole-resistant aspergillosis. N Engl J Med 356(14):1481–1483PubMedCrossRefGoogle Scholar
  84. 84.
    Warris A, Weemaes CM, Verweij PE (2002) Multidrug resistance in Aspergillus fumigatus. N Engl J Med 347(26):2173–2174PubMedCrossRefGoogle Scholar
  85. 85.
    Sallmann S, Heilmann A, Heinke F, Kerkmann ML, Schuppler M, Hahn G et al (2003) Capofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease. Pediatr Infect Dis J 22(2):199–200PubMedGoogle Scholar
  86. 86.
    Casson DH, Riordan FA, Ladusens EJ (1996) Aspergillus endocarditis in chronic granulomatous disease. Acta Paediatr 85(6):758–759PubMedCrossRefGoogle Scholar
  87. 87.
    Verweij PE, Varga J, Houbraken J, Rijs AJ, Verduynlunel FM, Blijlevens NM et al (2008) Emericella quadrilineata as cause of invasive aspergillosis. Emerg Infect Dis 14(4):566–572PubMedCrossRefGoogle Scholar
  88. 88.
    Mohammedi I, Eckert A, Thiebaut A, Piens MA, Malhiere S, Robert D (2005) Fatal Aspergillus nidulans pneumonia. Rev Med Interne 26(3):249–250PubMedCrossRefGoogle Scholar
  89. 89.
    Peyrade F, Boscagli A, Roa M, Taillan B, Gary-Toussain M, Dujardin P (1997) A. nidulans bronchial aspergillosis after treatment of low-grade lymphoma with fludarabine. Rev Med Interne 18(3):235–236PubMedCrossRefGoogle Scholar
  90. 90.
    Lucas GM, Tucker P, Merz WG (1999) Primary cutaneous Aspergillus nidulans infection associated with a Hickman catheter in a patient with neutropenia. Clin Infect Dis 29(6):1594–1596PubMedCrossRefGoogle Scholar
  91. 91.
    Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A et al (2010) Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 50(8):1101–1111PubMedCrossRefGoogle Scholar
  92. 92.
    Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50(8):1091–1100PubMedCrossRefGoogle Scholar
  93. 93.
    Burgos A, Zaoutis TE, Dvorak CC, Hoffman JA, Knapp KM, Nania JJ et al (2008) Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 121(5):e1286–e1294PubMedCrossRefGoogle Scholar
  94. 94.
    Kaltenis P, Mudeniene V, Maknavicius S, Seinin D (2008) Renal amyloidosis in a child with chronic granulomatous disease and invasive aspergillosis. Pediatr Nephrol 23(5):831–834PubMedCrossRefGoogle Scholar
  95. 95.
    Vinh DC, Shea YR, Sugui JA, Parrilla-Castellar ER, Freeman AF, Campbell JW et al (2009) Invasive aspergillosis due to Neosartorya udagawae. Clin Infect Dis 49(1):102–111PubMedCrossRefGoogle Scholar
  96. 96.
    Bruun JN, Solberg CO, Hamre E, Janssen CJ Jr, Thunold S, Eide J (1976) Acute disseminated phycomycosis in a patient with impaired neutrophil granulocyte function. Acta Pathol Microbiol Scand C 84(2):93–99PubMedGoogle Scholar
  97. 97.
    Bode CP, Schroten H, Koletzko S, Lubke H, Wahn V (1996) Transient achalasia-like esophageal motility disorder after candida esophagitis in a boy with chronic granulomatous disease. J Pediatr Gastroenterol Nutr 23(3):320–323PubMedCrossRefGoogle Scholar
  98. 98.
    Orson JM, Greco RG (1985) Chronic granulomatous disease and Torulopsis infections. Am J Dis Child 139(6):545PubMedGoogle Scholar
  99. 99.
    Malmvall BE, Follin P (1993) Successful interferon-gamma therapy in a chronic granulomatous disease (CGD) patient suffering from Staphylococcus aureus hepatic abscess and invasive Candida albicans infection. Scand J Infect Dis 25(1):61–66PubMedGoogle Scholar
  100. 100.
    Djalilian AR, Smith JA, Walsh TJ, Malech HL, Robinson MR (2001) Keratitis caused by Candida glabrata in a patient with chronic granulomatous disease. Am J Ophthalmol 132(5):782–783PubMedCrossRefGoogle Scholar
  101. 101.
    Rosh JR, Tang HB, Mayer L, Groisman G, Abraham SK, Prince A (1995) Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr 126(1):143–145PubMedCrossRefGoogle Scholar
  102. 102.
    Williamson PR, Kwon-Chung KJ, Gallin JI (1992) Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin Infect Dis 14(5):1023–1026PubMedCrossRefGoogle Scholar
  103. 103.
    Cohen-Abbo A, Edwards KM (1995) Multifocal osteomyelitis caused by Paecilomyces varioti in a patient with chronic granulomatous disease. Infection 23(1):55–57PubMedCrossRefGoogle Scholar
  104. 104.
    Silliman CC, Lawellin DW, Lohr JA, Rodgers BM, Donowitz LG (1992) Paecilomyces lilacinus infection in a child with chronic granulomatous disease. J Infect 24(2):191–195PubMedCrossRefGoogle Scholar
  105. 105.
    Castelli MV, astruey-Izquierdo A, Cuesta I, Monzon A, Mellado E, Rodriguez-Tudela JL et al (2008) Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother 52(8):2926–2928PubMedCrossRefGoogle Scholar
  106. 106.
    De Ravin SS, Challipalli M, Anderson V, Shea YR, Marciano B, Hilligoss D et al (2011) Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. Clin Infect Dis 52(6):e136–e143PubMedCrossRefGoogle Scholar
  107. 107.
    Bhat SV, Paterson DL, Rinaldi MG, Veldkamp PJ (2007) Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine. Scand J Infect Dis 39(1):87–90PubMedCrossRefGoogle Scholar
  108. 108.
    Jabado N, Casanova JL, Haddad E, Dulieu F, Fournet JC, Dupont B et al (1998) Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin Infect Dis 27(6):1437–1441PubMedCrossRefGoogle Scholar
  109. 109.
    Pfaller MA, Diekema DJ (2004) Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 42(10):4419–4431PubMedCrossRefGoogle Scholar
  110. 110.
    Nesky MA, McDougal EC, Peacock JE Jr (2000) Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin Infect Dis 31(3):673–677PubMedCrossRefGoogle Scholar
  111. 111.
    Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ (2002) Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis 34(12):1648–1650PubMedCrossRefGoogle Scholar
  112. 112.
    Meletiadis J, Meis JF, Mouton JW, Rodriquez-Tudela JL, Donnelly JP, Verweij PE (2002) In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 46(1):62–68PubMedCrossRefGoogle Scholar
  113. 113.
    Moylett EH, Chinen J, Shearer WT (2003) Trichosporon pullulans infection in 2 patients with chronic granulomatous disease: an emerging pathogen and review of the literature. J Allergy Clin Immunol 111(6):1370–1374PubMedCrossRefGoogle Scholar
  114. 114.
    Holland SM, Shea YR, Kwon-Chung J (2004) Regarding "Trichosporon pullulans infection in 2 patients with chronic granulomatous disease". J Allergy Clin Immunol 114(1):205–206PubMedCrossRefGoogle Scholar
  115. 115.
    Lestini BJ, Church JA (2006) Trichosporon pullulans as a complication of chronic granulomatous disease in a patient undergoing immunosuppressive therapy for inflammatory bowel disease. Pediatr Infect Dis J 25(1):87–89PubMedCrossRefGoogle Scholar
  116. 116.
    Santos PE, Piontelli E, Shea YR, Galluzzo ML, Holland SM, Zelazko ME et al (2006) Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease. Med Mycol 44(8):749–753PubMedCrossRefGoogle Scholar
  117. 117.
    Lyratzopoulos G, Ellis M, Nerringer R, Denning DW (2002) Invasive infection due to penicillium species other than P. marneffei. J Infect 45(3):184–195PubMedCrossRefGoogle Scholar
  118. 118.
    Boltansky H, Kwon-Chung KJ, Macher AM, Gallin JI (1984) Acremonium strictum-related pulmonary infection in a patient with chronic granulomatous disease. J Infect Dis 149(4):653PubMedCrossRefGoogle Scholar
  119. 119.
    Pastorino AC, Menezes UP, Marques HH, Vallada MG, Cappellozi VL, Carnide EM et al (2005) Acremonium kiliense infection in a child with chronic granulomatous disease. Braz J Infect Dis 9(6):529–534PubMedCrossRefGoogle Scholar
  120. 120.
    Uenotsuchi T, Moroi Y, Urabe K, Fukagawa S, Tsuji G, Matsuda T et al (2005) Cutaneous alternariosis with chronic granulomatous disease. Eur J Dermatol 15(5):406–408PubMedGoogle Scholar
  121. 121.
    Sutton DA, Thompson EH, Rinaldi MG, Iwen PC, Nakasone KK, Jung HS et al (2005) Identification and first report of Inonotus (Phellinus) tropicalis as an etiologic agent in a patient with chronic granulomatous disease. J Clin Microbiol 43(2):982–987PubMedCrossRefGoogle Scholar
  122. 122.
    Roilides E, Sigler L, Bibashi E, Katsifa H, Flaris N, Panteliadis C (1999) Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease. J Clin Microbiol 37(1):18–25PubMedGoogle Scholar
  123. 123.
    Kenney RT, Kwon-Chung KJ, Waytes AT, Melnick DA, Pass HI, Merino MJ et al (1992) Successful treatment of systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease. Clin Infect Dis 14(1):235–242PubMedCrossRefGoogle Scholar
  124. 124.
    Marques AR, Kwon-Chung KJ, Holland SM, Turner ML, Gallin JI (1995) Suppurative cutaneous granulomata caused by Microascus cinereus in a patient with chronic granulomatous disease. Clin Infect Dis 20(1):110–114PubMedCrossRefGoogle Scholar
  125. 125.
    McGinnis MR, Walker DH, Folds JD (1980) Hansenula polymorpha infection in a child with chronic granulomatous disease. Arch Pathol Lab Med 104(6):290–292PubMedGoogle Scholar
  126. 126.
    Sanchez FW, Freeland PN, Bailey GT, Vujic I (1985) Embolotherapy of a mycotic pseudoaneurysm of the internal mammary artery in chronic granulomatous disease. Cardiovasc Intervent Radiol 8(1):43–45PubMedCrossRefGoogle Scholar
  127. 127.
    Balajee SA, Houbraken J, Verweij PE, Hong SB, Yaghuchi T, Varga J et al (2007) Aspergillus species identification in the clinical setting. Stud Mycol 59:39–46PubMedCrossRefGoogle Scholar
  128. 128.
    Dellepiane RM, Tortorano AM, Liotto N, Laicini E, Di LG, Carnelli V et al (2008) Invasive Aspergillus nidulans infection in a patient with chronic granulomatous disease. Mycoses 51(5):458–460PubMedCrossRefGoogle Scholar
  129. 129.
    Notheis G, Tarani L, Costantino F, Jansson A, Rosenecker J, Friederici D et al (2006) Posaconazole for treatment of refractory invasive fungal disease. Mycoses 49(Suppl 1):37–41PubMedCrossRefGoogle Scholar
  130. 130.
    van ’t Hek LG, Verweij PE, Weemaes CM, van Dalen R, Yntema JB, Meis JF (1998) Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease. Am J Respir Crit Care Med 157(5 Pt 1):1694–1696PubMedGoogle Scholar
  131. 131.
    Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P et al (1999) Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol 37(10):3223–3228PubMedGoogle Scholar
  132. 132.
    Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M (2001) Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 97(6):1604–1610PubMedCrossRefGoogle Scholar
  133. 133.
    Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA et al (2008) Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst Rev 4:CD007394Google Scholar
  134. 134.
    Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van WE (2004) Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 170(6):621–625PubMedCrossRefGoogle Scholar
  135. 135.
    Neijens HJ, Frenkel J, de Muinck Keizer-Schrama SM, Dzoljic-Danilovic G, Meradji M, van Dongen JJ (1989) Invasive Aspergillus infection in chronic granulomatous disease: treatment with itraconazole. J Pediatr 115(6):1016–1019PubMedCrossRefGoogle Scholar
  136. 136.
    Denikus N, Orfaniotou F, Wulf G, Lehmann PF, Monod M, Reichard U (2005) Fungal antigens expressed during invasive aspergillosis. Infect Immun 73(8):4704–4713PubMedCrossRefGoogle Scholar
  137. 137.
    Weig M, Frosch M, Tintelnot K, Haas A, Gross U, Linsmeier B et al (2001) Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol 39(5):1721–1730PubMedCrossRefGoogle Scholar
  138. 138.
    Sendid B, Poirot JL, Tabouret M, Bonnin A, Caillot D, Camus D et al (2002) Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol 51(5):433–442PubMedGoogle Scholar
  139. 139.
    Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V (2003) The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 33(7):453–460PubMedCrossRefGoogle Scholar
  140. 140.
    Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46(3):327–360PubMedCrossRefGoogle Scholar
  141. 141.
    Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr et al (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48(5):503–535PubMedCrossRefGoogle Scholar
  142. 142.
    Van Der Linden JW, Warris A, Verweij PE (2010) Aspergillus species intrinsically resistant to antifungal agents. Med MycolGoogle Scholar
  143. 143.
    Kontoyiannis DP, Lewis RE, May GS, Osherov N, Rinaldi MG (2002) Aspergillus nidulans is frequently resistant to amphotericin B. Mycoses 45(9–10):406–407PubMedCrossRefGoogle Scholar
  144. 144.
    Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P et al (2002) Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 21(3):240–248PubMedCrossRefGoogle Scholar
  145. 145.
    Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II (2005) Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis 5(12):775–785PubMedCrossRefGoogle Scholar
  146. 146.
    Segal BH, Barnhart LA, Anderson VL, Walsh TJ, Malech HL, Holland SM (2005) Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis 40(11):1684–1688PubMedCrossRefGoogle Scholar
  147. 147.
    Rex JH, Bennett JE, Gallin JI, Malech HL, Melnick DA (1990) Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J Infect Dis 162(2):523–528PubMedCrossRefGoogle Scholar
  148. 148.
    Seger RA (2008) Modern management of chronic granulomatous disease. Br J Haematol 140(3):255–266PubMedCrossRefGoogle Scholar
  149. 149.
    Ozsahin H, von Planta M, Muller I, Steinert HC, Nadal D, Lauener R et al (1998) Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 92(8):2719–2724PubMedGoogle Scholar
  150. 150.
    Sastry J, Kakakios A, Tugwell H, Shaw PJ (2006) Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection. Pediatr Blood Cancer 47(3):327–329PubMedCrossRefGoogle Scholar
  151. 151.
    Clinical and Laboratory Standards Institute (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved standard—Second edition. CLSI document M38-A2, 2nd edn. Clinical and Laboratory Standards Institute, WayneGoogle Scholar
  152. 152.
    Verweij PE, Howard SJ, Melchers WJ, Denning DW (2009) Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat 12(6):141–147PubMedCrossRefGoogle Scholar
  153. 153.
    Segal BH (2007) Role of macrophages in host defense against aspergillosis and strategies for immune augmentation. Oncologist 12(Suppl 2):7–13PubMedGoogle Scholar
  154. 154.
    Condino-Neto A, Newburger PE (2000) Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Blood 95(11):3548–3554PubMedGoogle Scholar
  155. 155.
    Ishibashi F, Mizukami T, Kanegasaki S, Motoda L, Kakinuma R, Endo F et al (2001) Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene. Blood 98(2):436–441PubMedCrossRefGoogle Scholar
  156. 156.
    Ezekowitz RA, Dinauer MC, Jaffe HS, Orkin SH, Newburger PE (1988) Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med 319(3):146–151PubMedCrossRefGoogle Scholar
  157. 157.
    Ezekowitz RA, Orkin SH, Newburger PE (1987) Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. J Clin Invest 80(4):1009–1016PubMedCrossRefGoogle Scholar
  158. 158.
    Sechler JM, Malech HL, White CJ, Gallin JI (1988) Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci USA 85(13):4874–4878PubMedCrossRefGoogle Scholar
  159. 159.
    Muhlebach TJ, Gabay J, Nathan CF, Erny C, Dopfer G, Schroten H et al (1992) Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins. Clin Exp Immunol 88(2):203–206PubMedCrossRefGoogle Scholar
  160. 160.
    A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease (1991) The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med 324(8):509–516CrossRefGoogle Scholar
  161. 161.
    Woodman RC, Erickson RW, Rae J, Jaffe HS, Curnutte JT (1992) Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity. Blood 79(6):1558–1562PubMedGoogle Scholar
  162. 162.
    Gallin JI (1991) Interferon-gamma in the treatment of the chronic granulomatous diseases of childhood. Clin Immunol Immunopathol 61(2 Pt 2):S100–S105PubMedCrossRefGoogle Scholar
  163. 163.
    Weening RS, Leitz GJ, Seger RA (1995) Recombinant human interferon-gamma in patients with chronic granulomatous disease–European follow up study. Eur J Pediatr 154(4):295–298PubMedGoogle Scholar
  164. 164.
    Mouy R, Veber F, Blanche S, Donadieu J, Brauner R, Levron JC et al (1994) Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr 125(6 Pt 1):998–1003PubMedGoogle Scholar
  165. 165.
    Gallin JI, Alling DW, Malech HL, Wesley R, Koziol D, Marciano B et al (2003) Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 348(24):2416–2422PubMedCrossRefGoogle Scholar
  166. 166.
    Zambrano E, Esper F, Rosenberg R, Kim J, Reyes-Mugica M (2003) Chronic granulomatous disease. Pediatr Dev Pathol 6(6):577–581PubMedCrossRefGoogle Scholar
  167. 167.
    Al-Tawfiq JA, Al-Abdely HM (2010) Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma. Med Mycol 48(3):537–541PubMedCrossRefGoogle Scholar
  168. 168.
    Kim M, Shin JH, Suh SP, Ryang DW, Park CS, Kim C et al (1997) Aspergillus nidulans infection in a patient with chronic granulomatous disease. J Korean Med Sci 12(3):244–248PubMedGoogle Scholar
  169. 169.
    Bujak JS, Kwon-Chung KJ, Chusid MJ (1974) Osteomyelitis and pneumonia in a boy with chronic granulomatous disease of childhood caused by a mutant strain of Aspergillus nidulans. Am J Clin Pathol 61(3):361–367PubMedGoogle Scholar
  170. 170.
    Altman AR (1977) Thoracic wall invasion secondary to pulmonary aspergillosis: a complication of chronic granulomatous disease of childhood. Am J Roentgenol 129(1):140–142Google Scholar
  171. 171.
    Bukhari E, Alrabiaah A (2009) First case of extensive spinal cord infection with Aspergillus nidulans in a child with chronic granulomatous disease. J Infect Dev Ctries 3(4):321–323PubMedCrossRefGoogle Scholar
  172. 172.
    Soler-Palacin P, Margareto C, Llobet P, Asensio O, Hernandez M, Caragol I, Espanol T (2007) Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol (Madr) 35:83–89Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Stefanie Henriet
    • 1
  • Paul E. Verweij
    • 2
  • Steven M. Holland
    • 3
  • Adilia Warris
    • 1
  1. 1.Department of Pediatric Infectious Diseases and ImmunologyNijmegen Institute for Infection, Inflammation and Immunity, Radboud University Nijmegen Medical CentreNijmegenThe Netherlands
  2. 2.Department of Medical MicrobiologyNijmegen Institute for Infection, Inflammation and Immunity, Radboud University Nijmegen Medical CentreNijmegenThe Netherlands
  3. 3.Laboratory of Clinical Infectious DiseasesNational Institute of Allergy and Infectious Diseases, National Institutes of HealthBethesdaUSA

Personalised recommendations